BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 485496)

  • 1. [Diagnosis of cellular immune reactions against autologous and homologous tumor tissue in cervix cancer patients using the direct leukocyte migration inhibition test].
    Koenig UD
    Arch Gynecol; 1979 Jul; 228(1-4):597-8. PubMed ID: 485496
    [No Abstract]   [Full Text] [Related]  

  • 2. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on LMIT of cervical cancer (author's transl)].
    Yamamoto H
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1917-26. PubMed ID: 7211210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cellular immunity in carcinoma of the uterine cervix].
    Pasqualini RS; Giraudo Conesa LC; Chevallier R
    Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell mediated immune reactions to autologous and homologous tumor tissue in cervical cancer patients.
    Koenig UD
    Obstet Gynecol Surv; 1979 Nov; 34(11):857-9. PubMed ID: 523041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cell mediated immunity in cervical cancer patients: evaluation by in vitro leukocyte-migration-inhibition-assay (author's transl)].
    Koenig UD
    Arch Gynecol; 1978 Dec; 226(4):315-24. PubMed ID: 736631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell-mediated immunity in myoma uteri measured by the leukocyte migration inhibition test (author's transl)].
    Lunow E
    Zentralbl Gynakol; 1979; 101(8):515-22. PubMed ID: 463417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect macrophage migration inhibition response to 3-M KCl extract of gastric carcinoma.
    Akiyoshi T; Koba F; Kawaguchi M; Miyazaki S; Tsuji H
    J Natl Cancer Inst; 1982 Aug; 69(2):345-7. PubMed ID: 6955541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular antitumor immunity in an autologous system in stomach cancer].
    Kurtenkov OA
    Vopr Onkol; 1981; 27(6):36-40. PubMed ID: 7269415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte migration inhibition in vitro in untreated and methimazole-treated patients with Graves disease.
    Kálmán K; Fazakas S; Erdei I; Leövey A
    Acta Med Acad Sci Hung; 1976; 33(4):327-32. PubMed ID: 1037636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some immunologic characteristics of carcinoma of the colon and rectum.
    Elias EG; Elias LL
    Surg Gynecol Obstet; 1975 Nov; 141(5):715-8. PubMed ID: 1198304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
    Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-directed immunity in human neuroblastoma.
    Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML
    Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Examination of cell-mediated immunity using the leukocyte migration inhibition test in agarose].
    Zimmermann S; Felber F
    Z Gesamte Inn Med; 1977 Feb; 32(4):54-5. PubMed ID: 855396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.